Price
Target price
€5.85
€5.85
-2.910%
-0.18
-2.910%
€27.16
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Mind Medicine MindMed Inc. Stock
We can see a decrease in the price for Mind Medicine MindMed Inc.. Compared to yesterday it has lost -€0.180 (-2.910%).
With 15 Buy predictions and not the single Sell prediction the community is currently very high on Mind Medicine MindMed Inc..
Based on the current price of 5.85 € the target price of 27 € shows a potential of 361.93% for Mind Medicine MindMed Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Mind Medicine MindMed Inc. stock. Criterium "Unique positioning" gathered the most positive votes but regarding "Non-cyclic/Cyclic" there were negative voices in the community.
Pros and Cons of Mind Medicine MindMed Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Cons
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
Show more
Ratings data for MNMD provided by MarketBeat
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its price target lowered by analysts at Robert W. Baird from $27.00 to $16.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MNMD provided by MarketBeat
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
Show more
Ratings data for MNMD provided by MarketBeat